[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.113.179. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Evidence to Practice
January 2014

The Institute of Medicine Report Sodium Intake in Populations: Assessment of EvidenceSummary of Primary Findings and Implications for Clinicians

Author Affiliations
  • 1Department of Medicine, University of California, San Francisco
  • 2Division of General Internal Medicine, San Francisco General Hospital, University of California, San Francisco
  • 3University of California, San Francisco, Center for Vulnerable Populations at San Francisco General Hospital
  • 4Department of Epidemiology and Biostatistics, University of California, San Francisco
JAMA Intern Med. 2014;174(1):136-137. doi:10.1001/jamainternmed.2013.11818

An Institute of Medicine (IOM) expert committee was commissioned by the US Centers for Disease Control and Prevention to review the evidence linking reductions in sodium consumption to health outcomes, with an emphasis on studies of direct health outcomes (eg, stroke, myocardial infarction) rather than surrogate outcomes (eg, blood pressure). The committee was asked to focus particular attention on potential benefits and harms of reducing sodium consumption to a daily intake in the range of 1500 to 2300 mg/d and the impact of this reduction for high-risk subgroups.1

First Page Preview View Large
First page PDF preview
First page PDF preview
×